TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T88752	Ras-related C3 botulinum toxin substrate 1	B1X8JH	Sanguinarium Chloride	Investigative	68635	C20H14ClNO4	367.8	C[N+]1=C2C(=C3C=CC4=C(C3=C1)OCO4)C=CC5=CC6=C(C=C52)OCO6.[Cl-]	IC50 = 58000 nM	Poor binder
T88752	Ras-related C3 botulinum toxin substrate 1	BA1IT6	Chelerythrine chloride	Investigative	72311	C21H18ClNO4	383.8	C[N+]1=C2C(=C3C=CC(=C(C3=C1)OC)OC)C=CC4=CC5=C(C=C42)OCO5.[Cl-]	IC50 ~ 100000 nM	Poor binder
T88752	Ras-related C3 botulinum toxin substrate 1	BE79CJ	7,8-Dimethoxy-5-methylbenzo[c]phenanthridin-5-ium-2,3-diol;chloride	Investigative	25164618	C20H18ClNO4	371.8	C[N+]1=C2C(=C3C=CC(=C(C3=C1)OC)OC)C=CC4=CC(=C(C=C42)O)O.[Cl-]	IC50 = 54000 nM	Poor binder
T88752	Ras-related C3 botulinum toxin substrate 1	BIF4Z2	Dehydrostepholidine chloride	Investigative	363208	C19H18ClNO4	359.8	COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)O)O)OC.[Cl-]	IC50 = 63000 nM	Poor binder
T88752	Ras-related C3 botulinum toxin substrate 1	BK6A8P	Tetrahydroxycanadine HCl	Investigative	45483118	C17H18ClNO4	335.8	C1CN2CC3=C(CC2C4=CC(=C(C=C41)O)O)C=CC(=C3O)O.Cl	IC50 = 68000 nM	Poor binder
T88752	Ras-related C3 botulinum toxin substrate 1	BKEC32	6,7-Dimethoxy-1-methyl-3-naphthalen-2-ylisoquinoline;hydrochloride	Investigative	45483140	C22H20ClNO2	365.8	CC1=NC(=CC2=CC(=C(C=C12)OC)OC)C3=CC4=CC=CC=C4C=C3.Cl	IC50 = 58000 nM	Poor binder
T88752	Ras-related C3 botulinum toxin substrate 1	BN3KJ4	4-(6,7-Dimethoxy-1-methylisoquinolin-3-yl)benzene-1,2-diol hydrochloride	Investigative	135959763	C18H18ClNO4	347.8	CC1=NC(=CC2=CC(=C(C=C12)OC)OC)C3=CC(=C(C=C3)O)O.Cl	IC50 = 104000 nM	Poor binder
T88752	Ras-related C3 botulinum toxin substrate 1	BV3X1S	6-N-[2-[5-(Dimethylamino)pentan-2-ylamino]-6-methylpyrimidin-4-yl]-2-methylquinoline-4,6-diamine	Investigative	90655048	C22H31N7	393.5	CC1=CC(=C2C=C(C=CC2=N1)NC3=NC(=NC(=C3)C)NC(C)CCCN(C)C)N	IC50 = 95000 nM	Poor binder
T88752	Ras-related C3 botulinum toxin substrate 1	BY13JE	2-(4-Fluoro-3-nitrophenylamino)-N-(4-morpholinophenyl)acetamide	Investigative	9099810	C18H19FN4O4	374.4	C1COCCN1C2=CC=C(C=C2)NC(=O)CNC3=CC(=C(C=C3)F)[N+](=O)[O-]	IC50 = 57200 nM	Poor binder